TREM2 deficiency aggravates neuroinflammatory response and cognitive impairment via disease-associated microglia in Parkinson's disease models
- 4 October 2025
- journal article
- Published by Elsevier in Neurochemistry International
- Vol. 191, 106068
Abstract
No abstract availableKeywords
Funding Information
- China Postdoctoral Science Foundation (2023M730742)
- Key Technologies Research and Development Program of Guangzhou Municipality (202206010086)
- National Natural Science Foundation of China (82071419)
- National Natural Science Foundation of China (82301663)
- National Natural Science Foundation of China (82301420)
- Guangzhou Municipal Science and Technology Project (202201000005)
This publication has 37 references indexed in Scilit:
- TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson’s Disease Mice and LPS-Induced BV2 CellsMolecular Neurobiology, 2023
- TREM2: Potential therapeutic targeting of microglia for Alzheimer's diseaseBiomedicine & Pharmacotherapy, 2023
- Reduced TREM2 activation in microglia of patients with Alzheimer's diseaseFEBS Open Bio, 2021
- TREM2 overexpression rescues cognitive deficits in APP/PS1 transgenic mice by reducing neuroinflammation via the JAK/STAT/SOCS signaling pathwayExperimental Neurology, 2021
- Prevalence and Clinical Aspects of Mild Cognitive Impairment in Parkinson's Disease: A Meta‐AnalysisMovement Disorders, 2019
- Transcriptional regulation of homeostatic and disease‐associated‐microglial genes by IRF1, LXRβ, and CEBPαGlia, 2019
- Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s diseaseActa Neuropathologica, 2019
- Disease-Associated Microglia: A Universal Immune Sensor of NeurodegenerationCell, 2018
- TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson's diseaseExperimental Neurology, 2018
- A Unique Microglia Type Associated with Restricting Development of Alzheimer’s DiseaseCell, 2017